We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
2qu5
From Proteopedia
Contents |
Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor
Template:ABSTRACT PUBMED 17696416
About this Structure
2qu5 is a 1 chain structure of Vascular Endothelial Growth Factor Receptor with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Potashman MH, Bready J, Coxon A, DeMelfi TM Jr, DiPietro L, Doerr N, Elbaum D, Estrada J, Gallant P, Germain J, Gu Y, Harmange JC, Kaufman SA, Kendall R, Kim JL, Kumar GN, Long AM, Neervannan S, Patel VF, Polverino A, Rose P, Plas S, Whittington D, Zanon R, Zhao H. Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors. J Med Chem. 2007 Sep 6;50(18):4351-73. Epub 2007 Aug 15. PMID:17696416 doi:10.1021/jm070034i
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Gu, Y. | Kim, J L. | Long, A M. | Rose, P. | Whittington, D A. | Zhao, H. | Angiogenesis | Atp-binding | Developmental protein | Differentiation | Glycoprotein | Host-virus interaction | Immunoglobulin domain | Kdr | Membrane | Nucleotide-binding | Phosphorylation | Receptor tyrosinse kinase | Transferase | Transmembrane | Tyrosine-protein kinase
